A retrosynthetic biology approach to therapeutics: from conception to delivery.

Curr Opin Biotechnol

iSSB, Institute of Systems and Synthetic Biology, CNRS UPS3509, University of Evry-Val-d'Essonne EA4527, Genopole Campus 1, Genavenir 6, 5 rue Henri Desbruères, 91030 Evry Cedex, France.

Published: December 2012

De novo biosynthetic pathways are designed, assembled and optimized to produce high-value compounds such as drugs and chemical building blocks from renewable resources. Microorganisms are used as synthetic platforms of systems biology where biochemical pathways are engineered into the host metabolic network. Retrosynthetic biology offers a creative pathway design concept that has gained interest because of its potential to identify novel metabolic ways for therapeutic production. Retrosynthetic biology uses the backward search of retrosynthetic analysis to devise and optimize tailor-made pathways. The retrosynthetic process can be seamlessly integrated into a complete circuitry system for therapeutic applications where production, sensing and delivery act as constitutive interconnecting parts. The aim of this review is to highlight recent efforts toward synthetic design for therapeutic development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.copbio.2012.03.009DOI Listing

Publication Analysis

Top Keywords

retrosynthetic biology
12
retrosynthetic
5
biology approach
4
approach therapeutics
4
therapeutics conception
4
conception delivery
4
delivery novo
4
novo biosynthetic
4
biosynthetic pathways
4
pathways designed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!